Astrana Health (ASTH) Depreciation & Amortization (CF) (2010 - 2026)

Astrana Health (ASTH) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $15.5 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 126.0% year-over-year to $15.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (up 83.22% YoY) and the FY2025 annual result came in at $45.7 million, up 63.82% from the prior year.
• Depreciation & Amortization (CF) declined to $15.5 million in Q1 2026 per ASTH's latest filing, from $16.4 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $16.4 million in Q4 2025, with the low at $4.1 million in Q4 2022.
• Average Depreciation & Amortization (CF) over 5 years is $7.3 million, with a median of $5.1 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) retreated 9.46% in 2023 and jumped 126.0% in 2026.
• Astrana Health's Depreciation & Amortization (CF) stood at $4.1 million in 2022, then advanced by 20.65% to $4.9 million in 2023, then surged by 65.77% to $8.1 million in 2024, then surged by 101.83% to $16.4 million in 2025, then decreased by 5.62% to $15.5 million in 2026.
• Business Quant data shows ASTH's Depreciation & Amortization (CF) at $15.5 million in Q1 2026, $16.4 million in Q4 2025, and $15.6 million in Q3 2025.